EE9800181A - Gonadotropin-releasing hormone antagonist, its use, pharmaceutical composition and method of preparation - Google Patents
Gonadotropin-releasing hormone antagonist, its use, pharmaceutical composition and method of preparationInfo
- Publication number
- EE9800181A EE9800181A EE9800181A EE9800181A EE9800181A EE 9800181 A EE9800181 A EE 9800181A EE 9800181 A EE9800181 A EE 9800181A EE 9800181 A EE9800181 A EE 9800181A EE 9800181 A EE9800181 A EE 9800181A
- Authority
- EE
- Estonia
- Prior art keywords
- gonadotropin
- preparation
- pharmaceutical composition
- releasing hormone
- hormone antagonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US863495P | 1995-12-14 | 1995-12-14 | |
| GBGB9603369.1A GB9603369D0 (en) | 1996-02-16 | 1996-02-16 | Antagonists of gonadotropin releasing hormone |
| PCT/US1996/019443 WO1997021703A1 (en) | 1995-12-14 | 1996-12-10 | Antagonists of gonadotropin releasing hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE9800181A true EE9800181A (en) | 1998-12-15 |
Family
ID=26308742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9800181A EE9800181A (en) | 1995-12-14 | 1996-12-10 | Gonadotropin-releasing hormone antagonist, its use, pharmaceutical composition and method of preparation |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0871624A1 (en) |
| JP (2) | JPH11501329A (en) |
| KR (1) | KR19990072124A (en) |
| CN (1) | CN1208413A (en) |
| AU (1) | AU709090B2 (en) |
| CA (1) | CA2240048A1 (en) |
| CZ (1) | CZ183298A3 (en) |
| EA (1) | EA000829B1 (en) |
| EE (1) | EE9800181A (en) |
| HU (1) | HUP9902121A3 (en) |
| IL (1) | IL124613A0 (en) |
| MX (1) | MX9804850A (en) |
| NO (1) | NO982731L (en) |
| NZ (1) | NZ325014A (en) |
| PL (1) | PL327132A1 (en) |
| SK (1) | SK77598A3 (en) |
| WO (1) | WO1997021703A1 (en) |
Families Citing this family (57)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY112897A (en) | 1994-04-01 | 2001-10-31 | Lilly Co Eli | Ih-indole-3-glyoxylamide spla2 inhibitors |
| US6200957B1 (en) * | 1995-12-14 | 2001-03-13 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| JP3092947B2 (en) * | 1995-12-14 | 2000-09-25 | メルク エンド カンパニー インコーポレーテッド | Gonadotropin-releasing hormone antagonist |
| US5981550A (en) * | 1997-06-05 | 1999-11-09 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6156772A (en) * | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| AU728811B2 (en) * | 1997-06-05 | 2001-01-18 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6156767A (en) * | 1997-06-05 | 2000-12-05 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6004984A (en) * | 1997-06-05 | 1999-12-21 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| AU7806998A (en) * | 1997-06-05 | 1998-12-21 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| WO1998055470A1 (en) * | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US5985901A (en) * | 1997-06-05 | 1999-11-16 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| AU729663B2 (en) * | 1997-06-05 | 2001-02-08 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| GB9718833D0 (en) * | 1997-09-04 | 1997-11-12 | Merck Sharp & Dohme | Therapeutic agents |
| AU1197299A (en) * | 1997-10-28 | 1999-05-17 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| JP2002503661A (en) * | 1998-02-11 | 2002-02-05 | メルク エンド カムパニー インコーポレーテッド | Gonadotropin-releasing hormone antagonist |
| US6159975A (en) * | 1998-02-11 | 2000-12-12 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| SI20424A (en) * | 1998-03-05 | 2001-06-30 | Agouron Pharmaceuticals, Inc. | Non-peptide GnRH agents |
| US6077847A (en) * | 1998-04-02 | 2000-06-20 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6025366A (en) * | 1998-04-02 | 2000-02-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6228867B1 (en) | 1998-04-02 | 2001-05-08 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6110931A (en) * | 1998-04-02 | 2000-08-29 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US5985892A (en) * | 1998-04-02 | 1999-11-16 | Merck & Co., Ltd. | Antagonists of gonadotropin releasing hormone |
| US5998432A (en) * | 1998-04-02 | 1999-12-07 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6346534B1 (en) | 1998-09-23 | 2002-02-12 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| AU3868800A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| JP2002539124A (en) * | 1999-03-10 | 2002-11-19 | メルク エンド カムパニー インコーポレーテッド | 6-azaindole compounds as gonadotropin-releasing hormone antagonists |
| AU3514200A (en) | 1999-03-10 | 2000-09-28 | Merck & Co., Inc. | 6-azaindole compounds as antagonists of gonadotropin releasing hormone |
| JP2002538205A (en) | 1999-03-10 | 2002-11-12 | メルク エンド カムパニー インコーポレーテッド | 6-azaindole compounds as gonadotropin-releasing hormone antagonists |
| US6537998B1 (en) | 1999-10-15 | 2003-03-25 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| EP1255738B1 (en) | 2000-01-25 | 2012-03-07 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| GB0022670D0 (en) | 2000-09-15 | 2000-11-01 | Astrazeneca Ab | Molecules |
| US6583153B2 (en) | 2000-12-12 | 2003-06-24 | Ortho-Mcneil Pharmaceutical, Inc. | 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone |
| SE0100566D0 (en) * | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
| SE0101692D0 (en) * | 2001-05-14 | 2001-05-14 | Astrazeneca Ab | Compounds |
| WO2003013528A1 (en) | 2001-08-02 | 2003-02-20 | Neurocrine Biosciences, Inc. | Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| JP2005500356A (en) | 2001-08-02 | 2005-01-06 | ニューロクライン バイオサイエンシーズ， インコーポレイテッド | Gonadotropin releasing hormone receptor antagonist |
| WO2003011293A2 (en) | 2001-08-02 | 2003-02-13 | Neurocrine Biosciences, Inc. | Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| AU2002324586B2 (en) | 2001-08-02 | 2008-04-24 | Neurocrine Biosciences, Inc. | 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| US6673796B2 (en) | 2001-08-02 | 2004-01-06 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| WO2003068769A1 (en) | 2002-02-12 | 2003-08-21 | Pfizer Inc. | Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh) |
| CA2489252A1 (en) | 2002-06-13 | 2003-12-24 | Pfizer Inc. | Non-peptide gnrh agents, pharmaceutical compositions and methods for their use |
| ATE363481T1 (en) | 2002-08-21 | 2007-06-15 | Astrazeneca Ab | PYRAZOLE DERIVATIVES AS GNRH INHIBITORS |
| AU2003267551A1 (en) | 2002-08-21 | 2004-03-11 | Astrazeneca Ab | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone |
| TW200407127A (en) | 2002-08-21 | 2004-05-16 | Astrazeneca Ab | Chemical compounds |
| TW200413351A (en) | 2002-08-21 | 2004-08-01 | Astrazeneca Ab | Chemical compounds |
| GB0219472D0 (en) * | 2002-08-21 | 2002-10-02 | Astrazeneca Ab | Chemical compounds |
| BRPI0412314B8 (en) | 2003-07-07 | 2021-05-25 | Neurocrine Biosciences Inc | compound 3-[2(r)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl -pyrimidine-2,4(1h,3h)-dione, pharmaceutical composition comprising said compound and its use for the treatment of a condition related to sex hormone |
| CN100376246C (en) | 2003-07-07 | 2008-03-26 | 纽罗克里生物科学有限公司 | Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| WO2005007633A1 (en) | 2003-07-07 | 2005-01-27 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| DE102004033902A1 (en) | 2004-07-14 | 2006-02-16 | Zentaris Gmbh | New tetrahydrocarbazole compounds are neurokinin-1 receptor antagonists useful to treat or prevent e.g. pubertas praecox, hirsutism, polycystic ovary syndrome, hormone dependent neoplastic diseases and Alzheimer's disease |
| EP2308839B1 (en) * | 2005-04-20 | 2017-03-01 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds |
| KR20080031266A (en) * | 2005-06-10 | 2008-04-08 | 바이파 사이언스 인코포레이티드 | Parp modulators and treatment of cancer |
| EP2095818A1 (en) | 2008-02-29 | 2009-09-02 | AEterna Zentaris GmbH | Use of LHRH antagonists at non-castrating doses |
| TW201130854A (en) | 2009-12-22 | 2011-09-16 | Bayer Schering Pharma Ag | Pyridinone derivatives and pharmaceutical compositions thereof |
| WO2012175514A1 (en) | 2011-06-21 | 2012-12-27 | Bayer Intellectual Property Gmbh | Pyridinone derivatives and pharmaceutical compositions thereof |
| EP2978763B1 (en) * | 2013-03-27 | 2018-03-07 | VIIV Healthcare UK (No.5) Limited | 2-keto amide derivatives as hiv attachment inhibitors |
| CN113527254B (en) * | 2021-07-07 | 2022-05-03 | 北京华氏信华科生物科技有限公司 | 7-methoxy-1H-indole compound, preparation method, pharmaceutical composition and application |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA795239B (en) * | 1978-10-12 | 1980-11-26 | Glaxo Group Ltd | Heterocyclic compounds |
| US4544663A (en) * | 1984-05-07 | 1985-10-01 | Sandoz, Inc. | Indolamine derivatives as anti-fertility agents |
| US5030640A (en) * | 1989-01-05 | 1991-07-09 | Merck & Co., Inc. | Novel β-adrenergic agonists and pharmaceutical compositions thereof |
| TW449600B (en) * | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
-
1996
- 1996-12-10 SK SK775-98A patent/SK77598A3/en unknown
- 1996-12-10 AU AU12819/97A patent/AU709090B2/en not_active Ceased
- 1996-12-10 JP JP9522123A patent/JPH11501329A/en active Pending
- 1996-12-10 HU HU9902121A patent/HUP9902121A3/en unknown
- 1996-12-10 CZ CZ981832A patent/CZ183298A3/en unknown
- 1996-12-10 PL PL96327132A patent/PL327132A1/en unknown
- 1996-12-10 KR KR1019980704442A patent/KR19990072124A/en not_active Application Discontinuation
- 1996-12-10 CA CA002240048A patent/CA2240048A1/en not_active Abandoned
- 1996-12-10 NZ NZ325014A patent/NZ325014A/en unknown
- 1996-12-10 EE EE9800181A patent/EE9800181A/en unknown
- 1996-12-10 IL IL12461396A patent/IL124613A0/en unknown
- 1996-12-10 CN CN96199901A patent/CN1208413A/en active Pending
- 1996-12-10 EA EA199800564A patent/EA000829B1/en not_active IP Right Cessation
- 1996-12-10 EP EP96943624A patent/EP0871624A1/en not_active Withdrawn
- 1996-12-10 WO PCT/US1996/019443 patent/WO1997021703A1/en not_active Application Discontinuation
-
1998
- 1998-06-12 NO NO982731A patent/NO982731L/en not_active Application Discontinuation
- 1998-06-15 MX MX9804850A patent/MX9804850A/en unknown
-
2000
- 2000-02-08 JP JP2000030819A patent/JP2000186039A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MX9804850A (en) | 1998-09-30 |
| JPH11501329A (en) | 1999-02-02 |
| PL327132A1 (en) | 1998-11-23 |
| WO1997021703A1 (en) | 1997-06-19 |
| NZ325014A (en) | 2000-06-23 |
| EP0871624A1 (en) | 1998-10-21 |
| AU709090B2 (en) | 1999-08-19 |
| NO982731D0 (en) | 1998-06-12 |
| EA000829B1 (en) | 2000-04-24 |
| JP2000186039A (en) | 2000-07-04 |
| KR19990072124A (en) | 1999-09-27 |
| CZ183298A3 (en) | 1998-09-16 |
| HUP9902121A2 (en) | 1999-10-28 |
| CN1208413A (en) | 1999-02-17 |
| CA2240048A1 (en) | 1997-06-19 |
| IL124613A0 (en) | 1998-12-06 |
| AU1281997A (en) | 1997-07-03 |
| NO982731L (en) | 1998-08-13 |
| SK77598A3 (en) | 1999-01-11 |
| EA199800564A1 (en) | 1998-12-24 |
| HUP9902121A3 (en) | 2001-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE9800180A (en) | Gonadotropin-releasing hormone antagonist, its use, pharmaceutical composition and method of preparation | |
| EE9800181A (en) | Gonadotropin-releasing hormone antagonist, its use, pharmaceutical composition and method of preparation | |
| EE9800136A (en) | Pharmaceutical composition suitable for depot medicine, its preparation method and use | |
| EE9700328A (en) | Solid oral preparation containing olanzapine as active ingredient, method of preparation and use thereof | |
| EE04417B1 (en) | Oral pharmaceutical pulsatile dosage form, method of preparation and use | |
| EE9900296A (en) | Pharmaceutical composition of fenofibrates with high bioavailability and process for its preparation | |
| EE9800304A (en) | Particles, method of their preparation and use, pharmaceutical dosage form and method of their preparation, solid dispersion and pharmaceutical packaging | |
| EE03338B1 (en) | Anti-thrombotic drug, process for its preparation and use | |
| EE9500064A (en) | Substituted 1H-imidazoles, methods for their preparation, and pharmaceutical compositions | |
| EE03688B1 (en) | N- [4- (Heteroarylmethyl) phenyl] -heteroarylamines, their Preparation and Use, Pharmaceutical Composition and Method for its Preparation | |
| BR9603429A (en) | Derivative of 11- (substituted phenyl) estra-4,9-diene Preparation process of the same pharmaceutical composition and use of this derivative | |
| EE9900112A (en) | 2-Cyanoiminoimidazole derivatives, process for their preparation, use and pharmaceutical compositions | |
| EE04681B1 (en) | 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition | |
| EE200100314A (en) | A method of making a pharmaceutical composition, a pharmaceutical composition and its use | |
| NO942303D0 (en) | Pharmaceutical composition and method of preparation thereof | |
| EE04119B1 (en) | A pharmaceutical composition suitable for freeze-drying and a process for its preparation | |
| EE04087B1 (en) | The antimycotic composition, its use and method of preparation, and the antimycotic product | |
| EE9900034A (en) | Arylcycloalkanecarboxylic esters, their use, pharmaceutical compositions and their preparation | |
| EE04770B1 (en) | Tricyclic Delta3-Piperidines, Method of Preparation, Use, Pharmaceutical Composition and Method of Preparation | |
| EE03996B1 (en) | Pharmaceutical compositions, process for their preparation and use | |
| EE04260B1 (en) | Pharmaceutical composition, process for its preparation and use | |
| EE9800075A (en) | Combined medicinal product, its use and method of its preparation | |
| EE9700230A (en) | Bicyclic tachykinin antagonists, their preparation and use in pharmaceutical compositions | |
| EE200100305A (en) | Formulation, use and method of preparation | |
| EE200100210A (en) | Tricyclic 3-piperidines, process for their preparation, use, pharmaceutical composition and process for their preparation |